Fig. 4.

Effects of liraglutide on RCT and RCT-related protein expression in mice study. Liraglutide treatment increased the efflux of ³H-cholesterol from macrophages to plasma and feces in db/db mice with HFD (a), enhanced hepatic ABCA1 expression, and unchanged ABCG1 and SR-B1 expressions in mice (b). ****p < 0.0001: db/db + HFD vs db/db + ND or WT + ND ^##p < 0.01: db/db + HFD + LIRA vs db/db + HFD. ^&&&p < 0.001: db/db + HFD + AT vs db/db + HFD